X24-06-ZQ319 |
Src inhibitor 1-NA-PP1, Purity ≥98%
|
|
X24-06-ZQ321 |
Src inhibitor 7-Hydroxy-4H-chromen-4-one, Purity ≥98%
|
|
X24-06-ZQ322 |
Src inhibitor A-419259, Purity ≥98%
|
|
X24-06-ZQ323 |
Src inhibitor A-770041, Purity ≥98%
|
|
X24-06-ZQ324 |
Src inhibitor A419259, Purity ≥98%
|
|
X24-06-ZQ325 |
Src inhibitor AMG-47a, Purity ≥98%
|
|
X24-06-ZQ327 |
Src inhibitor AZM475271, Purity ≥98%
|
|
X24-06-ZQ328 |
Src inhibitor Bosutinib, Purity ≥98%
|
|
X24-06-ZQ329 |
Src inhibitor CGP77675, Purity ≥98%
|
|
X24-06-ZQ330 |
Src inhibitor CPDA, Purity ≥98%
|
|
X24-06-ZQ332 |
Src inhibitor Dasatinib hydrochloride, Purity ≥98%
|
|
X24-06-ZQ333 |
Src inhibitor DGY-06-116, Purity ≥98%
|
|
X24-06-ZQ334 |
Src inhibitor eCF506, Purity ≥98%
|
|
X24-06-ZQ335 |
Src inhibitor Elzovantinib, Purity ≥98%
|
|
X24-06-ZQ336 |
Src inhibitor KB SRC 4, Purity ≥98%
|
|
X24-06-ZQ337 |
Src inhibitor KIN001-051, Purity ≥98%
|
|
X24-06-ZQ338 |
Src inhibitor KX1-004, Purity ≥98%
|
|
X24-06-ZQ339 |
Src inhibitor KX2-391, Purity ≥98%
|
|
X24-06-ZQ340 |
Src inhibitor KX2-391 2HCl, Purity ≥98%
|
|
X24-06-ZQ341 |
Lck inhibitor 2, Purity ≥98%
|
|